Drug Trial News

RSS
Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FDA lifts partial clinical hold that paused enrollment of new patients in tazemetosta clinical trials

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

Biogen and Eisai announce results of LTE Phase 1b study of aducanumab for treating MCI

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

NIH launches clinical trial to test infusions of combination antibodies in people with HIV

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Sesen Bio to present its three-month Phase 3 VISTA Trial data at Global Congress

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Emergex signs MoU with Brazil’s Fiocruz for development of viral vaccines

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Cell Medica successfully doses first patient with CMD-501 targeting pediatric neuroblastoma

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Addition of CTLA4 targeted therapy to PD-1 targeted therapy may benefit patients with ovarian cancer

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

Alector announces initiation of Phase 1 trial of AL001 for treating frontotemporal dementia

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

AmpliPhi receives positive feedback from FDA for its AB-PA01 product targeting P.aeruginosa infections

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Novel clinical trial to examine cannabis as potential treatment for essential tremor

Investigational nasal influenza vaccine tested in children and teens

Investigational nasal influenza vaccine tested in children and teens

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Study reveals long-term safety, efficacy of Ofev in patients with idiopathic pulmonary fibrosis

Boehringer Ingelheim announces study results of COPD patients treated with Spiolto Respimat

Boehringer Ingelheim announces study results of COPD patients treated with Spiolto Respimat

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults

FDA approves Teva’s AJOVY injection for preventive treatment of migraine in adults